If a sudden urge to urinate has ever interrupted a walk, meeting, workout, road trip, or good night’s sleep, you already know that urgency urinary incontinence can affect much more than your bladder.
It can shape your schedule, limit your choices, and quietly reduce your confidence.
Now, a new medical technology is drawing attention. In August 2026, the FDA cleared Revi Extend, an implantable tibial neuromodulation system designed for urgency urinary incontinence, or UUI. The updated implant is designed to last up to 15 years, while therapy is delivered through a lightweight external wearable.
That does not mean Revi Extend is a guaranteed 15-year cure. It does mean women and their clinicians may soon have another long-term option to discuss.
Start by identifying the type of leakage
Not all urinary leakage is the same.
Urgency urinary incontinence involves urine loss associated with a sudden, difficult-to-control urge to urinate. You may feel that you need to find a bathroom immediately and still leak before getting there.
Stress urinary incontinence occurs when urine leaks during activities that place pressure on the bladder, such as coughing, sneezing, laughing, lifting, or exercising.
Some women experience both.
Revi Extend is designed for urgency urinary incontinence and urinary urgency. It is not a universal treatment for every type of bladder symptom. Ask your health care professional to evaluate the pattern of your symptoms before considering any procedure or device.
Understand why this matters in midlife
Many women notice bladder changes during perimenopause and menopause. Hormonal shifts can affect the tissues of the urinary and genital systems. Pelvic floor changes, childbirth history, constipation, urinary tract infections, medications, sleep disruption, and other health conditions can also contribute.
Yet many women normalize bladder leakage for years.
You may tell yourself:
- “This is just part of getting older.”
- “I should have gone to the bathroom before I left.”
- “I cannot exercise without planning around a restroom.”
- “I will bring extra protection, just in case.”
- “I am the only one dealing with this.”
You are not alone: and you do not have to accept persistent symptoms without support. Start the conversation with a primary care clinician, gynecologist, urogynecologist, or urologist. A clear diagnosis can open the door to behavioral strategies, pelvic floor therapy, medications, nerve stimulation, injections, or other treatments.
Reviewing your broader hormonal and metabolic health can also be valuable during this stage of life. Our Perimenopause Essentials resource can help you prepare for more informed conversations about changing symptoms.
See how Revi Extend works
Revi Extend uses a small implant placed near the ankle during a minimally invasive outpatient procedure.
The system is designed around three key elements:
- A small implant near the ankle: A clinician places the implant near the tibial nerve in the lower leg.
- An external wearable: The wearable sits over the implant during a therapy session.
- Targeted nerve stimulation: The wearable supplies energy to the implant, which delivers mild electrical stimulation to the posterior tibial nerve.
The implant does not contain an internal battery or traditional implanted leads. Instead, the external wearable powers the implant during therapy sessions.
According to the manufacturer’s patient information, implantation is performed during a single outpatient procedure under local anesthesia. Afterward, the patient uses the external wearable for clinician-prescribed therapy sessions, often at home.
The approach aims to offer therapy without repeated in-office stimulation visits or a larger implanted pulse generator. However, the procedure still involves surgery, and the technology requires appropriate patient selection, clinician programming, and consistent use.
Focus on the most important number: durable response
The Revi system’s longer-term results come from the pivotal OASIS trial, a prospective, multicenter, single-arm study of women with urgency urinary incontinence.
The study enrolled 151 women. At three years, data were available for 90 participants in the long-term assessment. Among those participants:
- 79% achieved at least a 50% reduction in urgency urinary incontinence episodes.
- 63% achieved at least a 75% reduction.
- 28% were dry on a three-day bladder diary.
- 95% of surveyed participants reported satisfaction with therapy.
- 82% reported feeling “much better” or “very much better.”
The reported responder rates remained generally consistent across follow-up points:
- 77.8% at six months
- 82% at nine months
- 79.4% at 24 months
- 79% at 36 months
That consistency is important. It suggests that the benefit observed early in the study did not disappear for most responding participants over the three-year follow-up period.
Still, read the data carefully. These percentages do not mean every patient improved, and the number of participants evaluated changed over time. A single-arm study also does not compare Revi directly with every other available treatment. Clinical trial results can inform a decision, but they cannot predict exactly how an individual woman will respond.
Read the published three-year study on PubMed and review the study record on ClinicalTrials.gov.
Recognize what the 15-year device life does: and does not: mean
The FDA clearance extends the stated implant life from 10 years to 15 years for Revi Extend.
That may reduce the need to consider replacement because of an expected device-life limit. It may also make the treatment feel more practical for women who want a long-term approach.
But separate device longevity from symptom longevity.
A 15-year implant life does not guarantee 15 years of symptom relief. It does not mean the implant will never require evaluation. It does not eliminate the possibility of side effects, device problems, changes in symptoms, or additional medical care.
The external wearable is a separate component. It has its own charging, maintenance, and service requirements. Your clinician also determines the therapy settings and helps you adjust the treatment plan if symptoms change.
Weigh the benefits with the risks
Every implant procedure deserves a careful, personal discussion.
Potential risks can include pain, bruising, swelling, infection, delayed wound healing, skin irritation, nerve injury, implant movement, and other complications associated with surgery. Stimulation may cause tingling, discomfort, changes in sensation, muscle spasms, or other unwanted effects.
The Revi patient guide also includes important precautions involving MRI, other implanted devices, electromagnetic interference, and certain medical procedures. Always tell every health care professional that you have an implant before receiving treatment or diagnostic testing.
The OASIS publication reported no device-related or procedure-related serious adverse events through 36 months. That is encouraging, but it does not mean that complications are impossible or that the technology is appropriate for everyone.
Use the published evidence as a starting point: not as a substitute for individualized medical advice.
Ask these questions before considering Revi Extend
Prepare for your appointment by asking:
- Do my symptoms indicate urgency incontinence, stress incontinence, or both?
- Could a urinary tract infection, medication, constipation, diabetes, or another condition be contributing?
- What treatments should I try before considering an implant?
- What would the procedure involve in my case?
- How often would I use the wearable?
- What symptoms should prompt me to contact the clinic?
- How would the implant affect future MRI scans or other procedures?
- What costs, insurance requirements, and follow-up visits should I expect?
- Is Revi Extend currently available in my area?
- What alternatives should I compare before deciding?
BlueWind Medical has announced a limited U.S. launch planned for the fourth quarter of 2026. Availability, clinician training, insurance coverage, and local access may vary.
Take back the conversation
Urinary leakage can feel embarrassing, but needing help does not make you weak, old, or broken. It makes you informed and proactive.
Notice the pattern. Track your symptoms. Bring a bladder diary to your appointment. Ask direct questions. Explore options that fit your health history, preferences, and goals.
Revi Extend represents an important development in women’s health technology because it offers a long-term, minimally invasive approach for appropriately selected women with urgency urinary incontinence. It is not a guaranteed fix, and it is not the only option. But it may give some women another powerful reason to believe that ongoing bladder disruption deserves evaluation: not resignation.
Find informed support for your next midlife health step at Midlife Resets.
Medical disclaimer: This article is for educational purposes only and does not diagnose, treat, or cure urinary incontinence or any other medical condition. The clinical results cited come from published and manufacturer-provided information about the Revi system and may not predict individual outcomes. Revi Extend is a prescription medical device, and FDA clearance does not guarantee that it is appropriate for you. Speak with a qualified health care professional about your symptoms, risks, treatment options, and whether this technology is available or suitable for your situation.